Severity of SARS-CoV-2 infection and the safety of COVID-19 vaccination in patients receiving HSCT

The coronavirus pandemic has put a great strain on worldwide healthcare systems. Patients with...

Fungal superinfections and COVID-19 in the ICU

The COVID-19 pandemic has caused a worldwide healthcare crisis. In addition to the morbidity caused by the initial infection, severely ill patients are...

COVID-19 vaccination for hematopoietic stem cell transplant patients

The SARS-CoV-2 pandemic has changed the world over the last year and impacted almost every part of our lives. In particular,...

How can we use microbial-derived metabolites to prevent GvHD?

During the 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), the GvHD Hub spoke to Erik Thiele...

Gut microbiota restoration after autologous fecal microbiota transfer in patients with AML

Intensive chemotherapy for acute myeloid leukemia (AML), along with prolonged exposure to multiple...

How can we use microbial-derived metabolites to prevent GvHD?

During the 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), the GvHD Hub spoke to Erik Thiele...

Phase II HERACLES trial meets its primary objective

On March 17, 2021, it was announced that the phase II HERACLES trial (NCT03359980), evaluating MaaT013 in patients with acute graft-versus-host...

What is the impact of conditioning regimens on microbiota?

During the 2021 TCT Meetings Digital Experience, the GvHD Hub spoke to Roni Shouval, Memorial Sloan Kettering Cancer Center, New York, US. We...

Consensus statements for pediatric GvHD: Recommendations from the EBMT Transplant Complications Working Party

Graft-versus-host disease (GvHD) remains a considerable contributor to mortality and...

Advances in the prognosis and treatment of acute GvHD

Acute graft-versus-host disease (aGvHD) remains a prominent issue following hematopoietic stem cell transplants and presents an incidence and...

The impact of non-classical symptoms of acute GvHD

Classically, the main organs that have been discussed with reference to acute graft-versus-host disease (aGvHD) have been the intestines, skin, and...

Comparison of posttransplant outcomes between haploidentical and matched unrelated donor recipients receiving PTCy prophylaxis

Triple posttransplant cyclophosphamide (PTCy)-based graft-versus-host...